Find out about ExCellThera's zemcelpro, the first blood cord expansion therapy to reach the European market, and only the second globally. The post Zemcelpro, the first blood cord expansion therapy to reach the EU market appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full an...| Labiotech.eu
Let us take a look at how the hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past few years.| Labiotech.eu